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Abstract
Background: Blinding trachoma, caused by ocular infection with Chlamydia trachomatis, is targeted for global elimination
by 2020. Knowledge of risk factors can help target control interventions.
Methodology/Principal Findings: As part of a cluster randomised controlled trial, we assessed the baseline prevalence of,
and risk factors for, active trachoma and ocular C. trachomatis infection in randomly selected children aged 0–5 years from
48 Gambian and 36 Tanzanian communities. Both children’s eyes were examined according to the World Health
Organization (WHO) simplified grading system, and an ocular swab was taken from each child’s right eye and processed by
Amplicor polymerase chain reaction to test for the presence of C. trachomatis DNA. Prevalence of active trachoma was 6.7%
(335/5033) in The Gambia and 32.3% (1008/3122) in Tanzania. The countries’ corresponding Amplicor positive prevalences
were 0.8% and 21.9%. After adjustment, risk factors for follicular trachoma (TF) in both countries were ocular or nasal
discharge, a low level of household head education, and being aged $1 year. Additional risk factors in Tanzania were flies
on the child’s face, being Amplicor positive, and crowding (the number of children per household). The risk factors for being
Amplicor positive in Tanzania were similar to those for TF, with the exclusion of flies and crowding. In The Gambia, only
ocular discharge was associated with being Amplicor positive.
Conclusions/Significance: These results indicate that although the prevalence of active trachoma and Amplicor positives
were very different between the two countries, the risk factors for active trachoma were similar but those for being
Amplicor positive were different. The lack of an association between being Amplicor positive and TF in The Gambia
highlights the poor correlation between the presence of trachoma clinical signs and evidence of C. trachomatis infection in
this setting. Only ocular discharge was associated with evidence of C. trachomatis DNA in The Gambia, suggesting that at
this low endemicity, this may be the most important risk factor.
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Introduction
Trachoma is caused by ocular infection with serovars A, B, Ba
or C of the bacterium Chlamydia trachomatis. It is the leading
infectious cause of blindness worldwide [1] with an estimated 40.6
million people suffering from active trachoma (trachomatous
inflammation, follicular (TF) and/or intense (TI)) and 8.2 million
having trichiasis [2]. As part of the ‘‘SAFE’’ (Surgery, Antibiotics,
Facial cleanliness, Environmental improvement) trachoma con-
trol strategy, the World Health Organization (WHO) recom-
mends mass antibiotic treatment annually for at least three years
of all individuals in any district or community where the
prevalence of TF in children aged 1–9 years is at least 10%.
After three or more years of A, F and E interventions, the
prevalence is reassessed and a decision is made regarding the need
to continue or cease treatment [3]. Mass antibiotic treatment aims
to clear infection from the community, most of which is found in
children [4].
Trachoma is endemic in both The Gambia and Tanzania, with
estimated active trachoma prevalences in children aged 1–9 years
of 10.4% and 27%, respectively [5,6]. Accordingly, they have both
recently qualified for a donation of the antibiotic azithromycin for
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mass treatment by Pfizer via the International Trachoma
Initiative. Given the different endemicities of these two countries,
one in which trachoma is almost disappearing and one in which
trachoma shows only modest signs of being reduced, the question
of whether the same risk factors are predictive of trachoma is of
interest. In addition, since the presence of trachoma clinical signs
is often poorly correlated with that of ocular C. trachomatis infection
[5,7,8,9,10,11], the risk factors for these markers of trachoma may
also differ.
Studies have shown that although young age is a common risk
factor for active trachoma, other risk factors may be setting-
specific. Furthermore, few studies have simultaneously reported
risk factors for active trachoma and ocular C. trachomatis
infection within the same setting [12,13]. Information on risk
factors can contribute to our understanding of trachoma
transmission within the study area, and the targeting of
trachoma control interventions can be aided through knowledge
of risk factors.
We aimed to assess the prevalence of, and risk factors for,
both active trachoma and ocular C. trachomatis infection pre-
treatment in The Gambia and Tanzania, as part of the
Partnership for the Rapid Elimination of Trachoma (PRET)
cluster randomised controlled trial. The aims of PRET are to
test the impact on the prevalence of active trachoma and ocular
C. trachomatis infection, as detected by Amplicor PCR, after three
years in communities mesoendemic for trachoma (between 20%
and 50% TF) or hypoendemic (between 10% and 20% TF),
when communities are randomised to different mass treatment
population coverage levels and a different number of rounds of
treatment, with a graduation rule if the prevalence of TF or
detected ocular C. trachomatis infection falls below 5% (Stare et al.
submitted).
The data presented here are from the baseline surveys of PRET,
where data on the prevalence of TF and evidence of ocular C.
trachomatis infection were collected, and risk factors for these
outcomes were obtained in a standardised fashion.
Methods
The study methods have been described in detail elsewhere
(Stare et al. submitted) and are summarised below. Reporting of
the study has been verified in accordance with the STROBE
(Strengthening the Reporting of Observational Studies in
Epidemiology) checklist (provided as supporting information,
Checklist S1).
Ethical approval
The research was done in accordance with the declaration of
Helsinki. Ethical approval was obtained from the London School
of Hygiene & Tropical Medicine (LSHTM), UK, Ethics
Committee; The Gambia government/Medical Research Council
(MRC) Joint Ethics Committee, The Gambia; the Johns Hopkins
Institutional Review Board; and the Tanzanian National Institute
for Medical Research. Oral consent was obtained from the village
leaders, and written (thumbprint or signature) consent from the
child’s guardian at the time of examination, which was signed by
an independent witness.
Site selection
In The Gambia, 48 census Enumeration Areas (EAs), designed
to have similar population sizes of between 600–800 people, were
randomly selected from within 4 strata consisting of the following
districts: Foni Bintang and Foni Kansala in Western Region, and
Central Baddibu and Lower Baddibu in North Bank Region (12
EAs per district) (Figure 1). In Tanzania, 32 communities
(geographically distinct areas within a village with an average
population of approximately 1500 people) were selected in
Kongwa district, Dodoma region (Figure 2). Tanzanian commu-
nities were selected based on having an active trachoma
prevalence above 20% in preliminary surveys and were therefore
not randomly selected as they were in The Gambia.
Data collection
A week-long workshop was conducted in February 2008 to
standardise all fieldwork methods, including trachoma grading,
photography, sample collection, form filling, facial cleanliness
status grading, and data entry. For trachoma grading, graders
were standardised against a senior grader (RB) every day by
examining participants in the field. A kappa of .0.6 for TF
grading was required between the senior grader and the graders in
the final grading exam. All other procedures had to be performed
correctly five times in the field under observation by senior
investigators before certification was given. Fieldwork in The
Gambia took place between 19th May 2008 and 29th July 2008. In
Tanzania, data collection was between 15th May and 1st
November 2008.
Census. Census collection differed between the two countries
as a result of high population movement within The Gambia,
which is not such a problem in Kongwa district, Tanzania. In The
Figure 1. Location of study districts in The Gambia.
doi:10.1371/journal.pntd.0000861.g001
Author Summary
Trachoma is caused by Chlamydia trachomatis and is the
leading infectious cause of blindness. The World Health
Organization’s (WHO) control strategy includes antibiotic
treatment of all community members, facial cleanliness,
and environmental improvements. By determining how
prevalent trachoma is, decisions can be made whether
control activities need to be put in place. Knowing what
factors make people more at risk of having trachoma can
help target trachoma control efforts to those most at
risk. We looked at the prevalence of active trachoma
and C. trachomatis infection in the eyes of children aged
0–5 years in The Gambia and Tanzania. We also measured
risk factors associated with having active trachoma or
infection. The prevalence of both active trachoma
and infection was lower in The Gambia (6.7% and
0.8%, respectively) than in Tanzania (32.3% and 21.9%,
respectively). Risk factors for active trachoma were similar
in the two countries. For infection, the risk factors in
Tanzania were similar to those for TF, whereas in
The Gambia, only ocular discharge was associated
with infection. These results show that although the
prevalence of active trachoma and infection is very
different between the two countries, the risk factors for
active trachoma are similar but those for infection are
different.
PRET Baseline Prevalence and Risk Factors
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Gambia a census was made of the de facto population (those who
had slept in the household the night before) within the week before
examination to limit absenteeism. In Tanzania the census included
all persons resident in the village for at least three months unless
newly arrived or newborn. In both countries, the census served as
the basis for making a random selection of 100 sentinel children
aged 0–5 years in each community for examination.
Examination. After obtaining consent, both upper eyelids of
the sentinel children were graded for active trachoma (TF and/or
TI) according to the WHO simplified grading system [14], using a
2.56 magnifying loupe and adequate sun or torch light. Two
photographs were taken from the right eye of all children in The
Gambia, and a random selection of children in Tanzania, using a
Nikon D-series camera and a Micro Nikon 105mm 1:2.8G lens
(Nikon, Tokyo, Japan). Photographs were used for grading quality
assurance after field data collection whereby a set of 50 photos per
grader was graded by the senior grader and the field examiners. A
kappa score of at least 0.6 between the examiners’ and senior
grader’s TF photo grading was required for the examiner to pass
the quality control exercise.
A fieldworker then passed a dacron swab (MDCI Ltd, Crawley,
UK, for The Gambia; Fisher Healthcare, Houston, TX, for
Tanzania) to the grader who took one swab from each child’s right
eye. The swab was held parallel to the conjunctiva and passed
three times with enough pressure to cause blanching, with a
rotation of 120u between each pass. The grader placed the swab in
a screw-top tube (VWR, Lutterworth, UK, for The Gambia;
Sarstedt AG & Co, Numbrecht, Germany, for Tanzania) and
snapped the swab’s stem. The tube was labelled with a unique ID
number, placed in a racked box in a cooler, and frozen within
10 hours. The grader changed gloves between each child to limit
cross-contamination. The fieldworker changed gloves when any
potential contamination of the gloves was thought to have
occurred.
For every 100 ocular swabs, at least three air controls were
taken at random. Immediately after the ocular swab was taken, a
new swab was passed 5 cm from the child’s everted right eyelid
five times, and labelled so that the control appeared as a genuine
sample to the laboratory staff. To further validate the laboratory
results and ensure standardisation between laboratories, a set of 20
mixed positive and negative samples were sent from each
laboratory to the external laboratory at the University of
California in San Francisco (UCSF) for processing. An agreement
of 90% was required to pass this validation exercise.
Risk factors. Household-level risk factor data were obtained
at the time of census using a questionnaire. Questions related to
the number of years of household head formal education, access to
a latrine, whether the time to fetch water was more than
30 minutes (with reference to a locally appropriate common
activity time), and awareness of the presence of a face-washing
campaign in the village within the last year that was not a radio or
television campaign. Child-level data on facial cleanliness,
measured by the presence of ocular discharge (‘‘sleep’’ on the
eyelashes or lids) or nasal discharge (discharge on the nares, cheeks
or lips), and whether any flies landed on the face during the time of
examination, were collected at the time of examination. All field
workers had been standardised during the initial workshop to
assess facial cleanliness indicators, and other risk factors, although
no measure of inter-observer variability was made.
Sample processing. Samples were tested for evidence of C.
trachomatis DNA by using the Amplicor Chlamydia trachomatis/
Neisseria gonorrhoeae (CT/NG) Test (Roche Molecular Systems,
Indianapolis, IN, USA) according to the manufacturer’s
instructions, except for sample extraction where previously
published protocols were employed for both the Gambian [15]
and Tanzanian [16] samples. In The Gambia, samples were tested
in pools of five due to the expected low prevalence of infection.
Samples from positive or equivocal pools were tested individually
to identify positive samples. The Gambian samples were processed
at the MRC laboratories, Fajara, The Gambia. The Tanzanian
samples were processed individually in the Johns Hopkins
International Chlamydia Laboratory, Baltimore, Maryland, USA.
Statistical analysis
Data were entered into a customised database (MS Access
v2007) developed at the Dana Center, Johns Hopkins University.
Key fields were double-entered by different entry clerks. Reports
of discrepant, missing or query entries were generated in the
database and resolved by reference to the forms, or in some cases
by return field visits. Further queries of data inconsistencies were
produced in statistical packages (Stata v10, STATA Corp., College
Station, TX, USA for the Gambian data; SAS v9.2, SAS Institute
Inc., Cary, NC, USA for the Tanzanian data) prior to analysis. All
queries were verified against the original paper forms. The
analyses presented here were conducted using Stata, v10.
Baseline characteristics of household attributes and population
size were summarised for both countries. Evidence of variability
between communities (clusters) and households was assessed using
random effects logistic regression models assuming a 3-level
hierarchy to the data structure (community, household and
individual) in null regression models.
Univariate associations with TF and ocular C. trachomatis
infection in children aged 0–5 years were tested using random
effects logistic regression, accounting for between-cluster and
between-household variation (variance), comparing models with
and without covariates using the likelihood ratio test (LRT).
Multivariate model building for TF and C. trachomatis infection in
both countries employed the same stepwise strategy; age and sex
Figure 2. Location of Kongwa district in Tanzania.
doi:10.1371/journal.pntd.0000861.g002
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were considered a priori risk factors and included in all models.
Covariates associated with TF or evidence of C. trachomatis
infection at the 10% significance level in univariate analyses were
added in turn (a forward stepwise approach) and covariates
retained in the model if the LRT p-value was #0.1. In The
Gambia, the final multivariate model also adjusted for district to
account for sampling stratified by district.
Results
Quality control
Grading validation. In Tanzania, the two trachoma graders
achieved a kappa score on the photo grading against the senior
grader for TF of 0.92 and 0.84. In The Gambia, the results for the
three graders were 0.81, 0.67, and 0.38. The grader who did not
reach the required kappa score of 0.6 had achieved a kappa of
0.70 between their field grade and the senior grader’s photo
grading. It was noted that a number of the photos were difficult to
grade owing to reflected light and/or poor presentation of the lid.
The grader was asked to grade a parallel set of baseline photos
from The Gambia which were technically more satisfactory, and
achieved a kappa score of 0.79.
Air controls. In The Gambia, 280 air controls were collected,
and one (0.4%) was positive, which was confirmed at both the
MRC and UCSF laboratories. This sample was negative when
tested for human mitochondrial DNA (mtDNA) using a previously
reported method [5], and the corresponding child’s sample did
contain mtDNA indicating there had not been an exchange
between the child’s sample and the air control. The child’s sample
was Amplicor negative and the eye was graded as clinically normal
both in the field and on the photograph by the senior grader. The
adjacent field and Amplicor plate samples were Amplicor negative.
In Tanzania, 142 air controls were collected and 7 (4.9%) were
positive by Amplicor. After reviewing the records, 2 were the result
of mis-labelling of the samples (one in the field, one in the
laboratory), and the remaining 5 were part of 4 runs that were
discarded because of suspected laboratory contamination.
Laboratory standardisation. Of 20 mixed positive and
negative samples sent to UCSF for re-testing from Tanzania, 17
were concordant, 1 was inhibitory twice and thus considered
negative and 2 were discrepant (both positive at JHU but negative
at UCSF). This triggered a request for an additional 20 samples to
be sent to UCSF, of which 19 were concordant, exceeding the
90% required agreement between the laboratories. JHU also
reprocessed the initial set of samples, repeating the same number
of freeze-thaw cycles as UCSF, and all re-run samples were
concordant with UCSF laboratory testing.
Of the 20 samples sent from The Gambia, all negatives were
confirmed negative except for one which was inhibited. Of the
positives, 3 were confirmed positive, 2 were inhibited, and 6 were
negative. This prompted another 20 samples to be sent to UCSF.
Of these, 18 (90%) were concordant. All 12 negatives were
confirmed negative, and 6 of the 8 positives were confirmed
positive. The remaining 2 samples that were positive in The
Gambia tested negative by Amplicor at UCSF.
Overview of communities and households
In The Gambia, 5033 children aged 0–5 years were examined.
In Tanzania, 3198 children were examined but ocular C.
trachomatis data were missing from 76 of these children. In The
Gambia, there were 9 households with missing data for awareness
of a village face-washing education programme. In Tanzania, the
number of missing values was 5 for household head education, 6
for time to water, 20 for latrine access, and 693 (of which 677 were
recorded as ‘‘unknown’’) for knowledge of a face-washing health
education programme.
Community randomisation units were larger in Tanzania than
in The Gambia, containing more, smaller households, as seen
from the total population size and average household sizes
(Table 1), although similar proportions of the total population
were children aged under 10 years. Household heads in The
Gambia had less formal education than in Tanzania, whereas
latrines and water were less easily accessible in Tanzania. Around
one third of households in both countries reported awareness of
receiving community face-washing health education programmes.
Prevalence of active trachoma and ocular C. trachomatis
infection
The Gambia. A total of 5036 children aged 0–5 years were
examined in The Gambia with only 3 missing values for clinical
sign data. The overall prevalence of TF in 0–5 year-olds in The
Gambia was 6.3% (95% CI: 5.6–7.0). Only 28 (0.6%) children had
TI, and 97 (1.9%) had follicles that did not fulfil the WHO
simplified grading system criteria for TF (5 or more follicles in the
upper tarsal conjunctiva of at least 0?5 mm). Overall, less than 1%
of children sampled in The Gambia tested positive by Amplicor.
There was a poor correlation between the presence of ocular C.
trachomatis infection and active trachoma. Indeed, the majority of
infected individuals in The Gambia were recorded as being
clinically normal (Table 2). Those with both TF and TI were more
likely to be Amplicor positive.
Tanzania. In Tanzania, a total of 3198 children aged 0–5
years were examined, with Amplicor results missing for 76
children. Approximately a third of the examined children had
TF (30.9%, 95% CI: 29.3–32.6), and around half of those were
Amplicor positive, demonstrating a strong association between TF
and evidence of infection, which was not seen in The Gambia
(Table 2). A total of 244 (7.8%) children had TI, and as seen in
The Gambia, children with both TF and TI were more likely to be
Amplicor positive. Of children examined, 15.5% had fewer than 5
follicles and therefore did not fulfil the WHO simplified grading
system criteria for TF.
Risk factors for TF
Univariate analysis. There was substantial variation at
household and cluster levels in both countries (LRT p,0.001).
Table 1. Baseline characteristics by study site.
The Gambia Tanzania
Communities 48 32
Households 3122 10011
No. people/household, median (IQR) 9 (6–14) 4 (3–6)
Household head years of education, median (IQR) 0 (0–0) 0 (0–7)
.30 minutes to water 410 (13.1) 7536 (75.3)
Latrine access 2798 (89.6) 6489 (64.8)
Health education programmea 1053 (33.7) 3390 (33.9)
Total Population 33695 46634
Children 0–5 years 7178 (21.3) 11587 (24.8)
Male children 0–5 years 3659 (10.9) 5769 (12.4)
Data are n (%) unless otherwise stated.
aHouseholders were each asked if they recalled a health education program in
their community in the previous year.
doi:10.1371/journal.pntd.0000861.t001
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For example, if the Gambian baseline is regarded as a survey in
which EAs are sampled from each district, and then children
sampled within each EA, the overall design effect for TF was 3.4.
There are data justifying the need for 3-levels in random effects
regression models. For TF in The Gambia, the between-household
variation was 1.11 (standard error (SE) 0.34) and between-cluster
variation 1.10 (SE 0.32). For TF in Tanzania, the between-
household variation was 1.31 (SE 0.45) and between-cluster
variation was 0.75 (SE 0.17). Amplicor laboratory data in
Tanzania between-household variation was 6.23 (SE 1.55) and
between-cluster variation was 6.23 (SE 1.55). Similar data could
not be generated for The Gambia, where only 39 children were
Amplicor positive.
In both The Gambia and Tanzania, increased risk (modelled as
odds in logistic regression models) of TF was seen for children with
ocular or nasal discharge, and flies on the face, at the 5% level of
significance. In both countries, there was a departure from a linear
trend in risk of TF with increasing age (LRT p,0.001).
Consequently, age was modelled as a categorical variable in
multivariate analyses. There was possibly a weak unadjusted effect
of increased time to fetch water on TF (p = 0.096) (Table 3).
Additional risk factors in Tanzania were being Amplicor positive,
not having access to a latrine, and possibly more children aged 0 to
5 years per household (Table 3).
An association between household head education in Tanzania
with decreased risk of TF was seen when it was considered as a
continuous variable (p = 0.001). When using cut-off values of the
25th, 50th and 75th percentiles, TF in children where the household
head had 1–3 years of education (Wald p= 0.440) and 4–6 years of
education (Wald p= 0.538) was not different to the reference
category of 0 years. The categorical variable was therefore
compressed for increased power to a binary variable, with
categories 0–6 years and 7+ years of household head education.
In The Gambia, very few children had TF in households where
the household head had at least one year of education and
categorisation was made into 0 years and at least one year, to
indicate some level of education (Table 3).
Multivariate analysis. In The Gambia, covariates added in
turn after a priori inclusion of age and sex to the model, were ocular
and nasal discharge, flies on the child’s face, education of the
household head (categorised as 0 years or $1 year) and time to
primary water source. In Tanzania, the covariates added in turn
were ocular and nasal discharge, flies on the child’s face, being
Amplicor positive, total household size, and education of the
household head (categorised as 0–6 years or 7+ years).
The final multivariable regression model for each country
demonstrated that being aged $1 year, ocular and nasal
discharge, and no or reduced levels of household head education
remained associated with increased risk of TF. These were true for
both settings. In The Gambia, there was weak evidence that poor
access to water was associated with TF. In Tanzania, after
adjustment, observing flies on the face, being Amplicor positive,
and an index of crowding (an increase in the number of children
aged 0–5 years per household), were additionally related to an
increase in TF (Table 4).
Risk factors for ocular C. trachomatis infection
The low prevalence of Amplicor positives in The Gambia
provided little power for formal risk factor analyses (Table 5). Chi-
squared tests of association suggested that ocular discharge was a
possible risk factor for an Amplicor positive result (p = 0.044) and
that prevalence varied by district (p,0.001). In Tanzania,
Amplicor positivity was associated in univariate analyses with
being aged $1 year, having ocular or nasal discharge, flies on the
child’s face, lack of household head education, and poor access to
water or a latrine (Table 5). In multivariate models, being
Amplicor positive was only significantly related to being aged 2–5
years, having discharge, and a head of household educational level
of less than 7 years, and possibly poor access to water (Table 5).
Other factors were not related to evidence of C. trachomatis
infection.
Discussion
As expected, the TF and Amplicor positive prevalences were
lower in the Gambian than in the Tanzanian sample, with pre-
treatment prevalences similar to reported national estimates [5,6].
The Gambia and Tanzania have different trachoma control
profiles. The Gambia is the smallest country on the African
continent. Its National Eye Care Programme (NECP) has been in
operation since 1986, which covered the whole country by 1996
[17]. There is also evidence of trachoma decline in the absence of
specific control interventions but associated with improvements in
sanitation, water supply, education, and access to health care in
the villages [18]. In contrast, the national trachoma control
programme in Tanzania started in 1999, with SAFE incorporated
into the district health plan of 12 of the 50 trachoma-endemic
districts by 2008 [19]. Mass azithromycin treatment in The
Gambia began in November 2007, whereas in Tanzania
distribution programmes started in 1999.
The risk factor data suggested similarities between the two
countries in that TF was related to signs of an unclean face
(ocular or nasal discharge), the level of household head education,
and the child being aged $1 year. In the multivariate models, the
association with access to water in The Gambia was weak and
there was no association in Tanzania, suggesting that univariate
associations were driven by confounding with education or facial
cleanliness markers. Interestingly, there were additional risk
factors for TF in Tanzania: being Amplicor positive, an index of
crowding (the number of children per household), and flies on
the children’s faces. This may reflect that transmission of C.
trachomatis is easier and more frequent in Tanzania, though we did
not find an association between evidence of being Amplicor
positive and crowding or flies on the face. It may be that through
crowded conditions and exposure to flies, there is continual
stimulation of the follicular immune response because of
unhygienic living conditions, or the presence of a low level of
inoculum that either does not lead to productive infection or a
short lived infection.
Table 2. Correlation between disease and ocular C.
trachomatis infection in children aged 0–5 years.
The Gambia Tanzania
N
Amplicor
positive, n (%) N
Amplicor
positive, n (%)
No trachoma 4698 36 (0.8) 2114 191 (9.0)
TF only 307 2 (0.7) 764 323 (42.3)
TI only 19 0 (0) 45 22 (48.9)
TF & TI 9 1 (11.1) 199 148 (74.4)
Total 5033 39 (0.8) 3122 684 (21.9)
TF = trachomatous inflammation, follicular; TI = trachomatous inflammation,
intense; ocular C. trachomatous infection measured by Amplicor.
doi:10.1371/journal.pntd.0000861.t002
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Some level of education for the household head was a protective
factor for TF in both settings. In The Gambia, few household
heads had formal education, as has previously been documented
[20], whereas Tanzanian household head formal education was
better. A higher education level, a possible proxy for higher socio-
economic status, has been associated with reduced risk of
trachoma in other studies [21,22]. In Egypt, low service utilisation
has been associated with low educational and socio-economic level
[23], which may be an explanation for the protective effect
afforded by a greater number of years of household head
education.
Knowledge of a health education programme in the village was
not associated with TF in either setting. A third of Tanzanian
households reported knowing of a health education programme,
which is similar to that previously reported in the same Tanzanian
district [24]. However, 693 households had missing data for this
variable, based on the households reporting ‘‘don’t know’’ to the
question. Thus, this may not be the most reliable method of
collecting data on the presence of health education programmes in
communities since recall may be poor. The proportion of
households in The Gambia aware of a health education
programme was similar to that in Tanzania, despite village health
workers not being required to conduct village-level hygiene
sessions as they are in Tanzania. In Tanzania, the households
that responded ‘‘don’t know’’ may have done so if they did not
consider the hygiene promotion provided by village health workers
as formal health education. Health education programmes have
previously been associated with clean faces when examined in
Table 3. Univariate TF risk factor analyses in children aged 0–5 years in The Gambia and Tanzania.
The Gambia Tanzania
Characteristic N TF, n (%) OR (95% CI) p-valuea N TF, n (%) OR (95% CI) p-valuea
Child level
Total 5033 316 (6.3) - - 3198 981 (30.7) - -
Age (years) 0 792 13 (1.6) 1 ,0.001 561 56 (10.0) 1 ,0.001
1 805 50 (6.2) 4.90 (2.51–9.58) 484 127 (26.2) 4.80 (2.96–7.77)
2 801 62 (7.7) 6.64 (3.44–12.8) 578 200 (34.6) 8.64 (5.24–14.3)
3 895 65 (7.3) 6.53 (3.39–12.6) 567 230 (40.6) 13.1 (7.80–22.2)
4 823 69 (8.4) 7.14 (3.72–13.7) 515 203 (39.4) 12.6 (7.42–21.4)
5 917 57 (6.2) 5.65 (2.92–10.9) 493 165 (33.5) 8.52 (5.11–14.2)
Sex Female 2272 168 (6.9) 1 0.125 1579 486 (30.8) 1 0.931
Male 2445 148 (5.7) 0.82 (0.63–1.06) 1619 495 (30.6) 0.99 (0.81–1.21)
Ocular Discharge No 4577 231 (5.1) 1 ,0.001 2884 829 (28.7) 1 ,0.001
Yes 444 83 (18.7) 4.47 (3.19–6.26) 303 149 (49.2) 2.66 (1.92–3.70)
Nasal Discharge No 3369 160 (4.8) 1 ,0.001 1649 416 (25.2) 1 ,0.001
Yes 1654 155 (9.4) 2.15 (1.63–2.82) 1537 562 (36.6) 1.99 (1.60–2.47)
Flies on the face No 4278 255 (6.0) 1 0.019 3011 887 (29.5) 1 ,0.001
Yes 739 57 (7.7) 1.55 (1.08–2.22) 175 91 (52.0) 2.42 (1.58–3.73)
Amplicor positive No 4990 313 (6.3) 1 0.959 2438 492 (20.2) 1 ,0.001
Yes 39 3 (7.7) 1.04 (0.27–4.00) 684 471 (68.9) 14.1 (9.38–21.1)
Household level
Number of people/
householdb
All residents - - 1.00 (0.98–1.02) 0.932 - - 1.04 (1.00–1.09) 0.061
Children 0–5 - - 1.03 (0.97–1.09) 0.348 - - 1.12 (0.99–1.27) 0.075
Household head
education
Gm: None
Tz: 0–6 years
4733 310 (6.6) 1 0.017 1678 567 (33.8) 1 0.001
Gm: $1 year
Tz: 7+ years
300 6 (2.0) 0.36 (0.14–0.91) 1518 413 (27.2) 0.70 (0.56–0.87)
Time to water ,30 minutes 4320 259 (6.0) 1 0.096 738 178 (24.1) 1 0.007
$30 minutes 713 57 (8.0) 1.47 (0.94–2.30) 2459 803 (32.7) 1.52 (1.12–2.07)
Latrine access No 386 31 (8.0) 1 0.431 1082 381 (35.2) 1 0.012
Yes 4647 285 (6.1) 0.80 (0.47–1.37) 2114 600 (28.4) 0.75 (0.59–0.94)
Health education
programmec
No 3342 185 (5.5) 1 0.926 1860 584 (31.4) 1 0.209
Yes 1667 128 (7.7) 0.98 (0.70–1.38) 1177 328 (27.9) 0.86 (0.67–1.09)
TF = trachomatous inflammation, follicular; OR =Odds Ratio; CI = Confidence Interval.
ap-value from likelihood ratio test comparing random effects logistic regression models adjusting for between-household and between-cluster variation with, and
without, characteristic of interest.
bvariables modelled as continuous measures.
chead of household recall of community health education program.
doi:10.1371/journal.pntd.0000861.t003
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clinics, indicating the potential impact that these programmes can
have on facial cleanliness [24]. However, there is evidence that
health education alone does not result in effective behaviour
change [25,26].
Both ocular and nasal discharge were associated with increased
risk of TF in both settings. Discharge has been closely associated
with active trachoma in many studies, including those from
Tanzania and The Gambia [20,27,28,29], but the causal
relationship remains unclear. Infected discharge may aid trans-
mission via fingers, flies or fomites. Discharge may however also be
the consequence of trachoma, as inflammation of the conjunctiva
could result in discharge being produced [20,24].
Less than 10% of children had ocular discharge or flies on their
face in Tanzania, although nearly half had nasal discharge. The
association between TF and flies in Tanzania accords with
previous risk factor studies from this country [13,29,30,31]. In The
Gambia, the prevalence of flies on the face was higher (14.7%),
ocular discharge was similar (8.8%), and nasal discharge was less
(32.9%), than in Tanzania. In The Gambia, flies were not
associated with TF after adjustment for age, sex, ocular and nasal
discharge, indicating that the univariate effect of flies was
explained by discharge. This is consistent with the finding by
Emerson et al. in The Gambia that those with discharge had twice
the fly-eye contacts of those without [32]. In Tanzania, the
strength of the individual associations of ocular discharge, nasal
discharge and flies on the face with TF was slightly weaker in the
multivariate model than in the univariate model. In particular, the
association with flies showed only some evidence of an association
once adjusted for ocular and nasal discharge, indicating that some
of the univariate association was explained by the presence of
discharge.
If the presence of either nasal or ocular discharge is combined
into a single sign of an unclean face, then the prevalence of
unclean faces in the sentinel children in Tanzania, 50.9%, was
greater than in The Gambia, 37.5%, perhaps reflective of the
higher rate of trachoma and infection in the Tanzanian setting.
Thus, despite similar awareness of health education, The Gambia
appears to have better facial cleanliness. However, in our study,
facial status was recorded at the time of examination and could
therefore reflect parents cleaning their children’s faces before
taking them for screening, leading to an under-estimate [24].
Latrine access was not associated with TF in either country. In
Tanzania, household latrine access was 64.8%, indicating that
latrine provision at these levels may be sufficient. The provision of
latrines is expected to result in a reduction in flies because Musca
sorbens (the putative trachoma vector) has been seen to preferen-
Table 4. Multivariate TF risk factor analyses in children aged 0–5 years in The Gambia and Tanzania.
The Gambia Tanzania
Characteristic OR (95% CI) p-valuea OR (95% CI) p-valuea
Child level
Total - -
Age (years) 0 1 1
1 4.77 (2.38–9.58) ,0.001 4.26 (2.60–6.99) ,0.001
2 5.98 (3.01–11.9) ,0.001 6.67 (4.05–11.1) ,0.001
3 6.37 (3.22–12.6) ,0.001 10.0 (5.95–16.8) ,0.001
4 7.20 (3.65–14.2) ,0.001 7.48 (4.49–12.5) ,0.001
5 6.81 (3.41–19.6) ,0.001 5.37 (3.26–8.84) ,0.001
Sex Female 1 1
Male 0.78 (0.60–1.02) 0.071 1.09 (0.87–1.36) 0.463
Ocular Discharge No 1 1
Yes 4.16 (2.92–5.92) ,0.001 1.92 (1.32–2.80) 0.001
Nasal Discharge No 1 1
Yes 1.63 (1.23–2.17) 0.001 1.53 (1.21–1.94) ,0.001
Flies on the face No - - 1
Yes - - 1.68 (1.04–2.73) 0.035
Amplicor positive No - - 1 ,0.001
Yes - - 14.07 (8.98–22.0)
Household level
Number of people/householdb Children 0–5 - - 1.18 (1.02–1.36) 0.027
Household head education Gm: None
Tz: 0–6 years
1 1
Gm: $1 year
Tz: 7+ years
0.42 (0.16–1.09) 0.075 0.77 (0.60–0.98) 0.032
Time to water ,30 minutes 1 - -
$30 minutes 1.50 (0.95–2.34) 0.079 - -
TF = trachomatous inflammation, follicular; OR =Odds Ratio; CI = Confidence Interval; Analyses adjusted for variables included in final multivariable regression model.
ap-value from Wald test in multivariable regression analysis.
bvariable modelled as continuous measures.
doi:10.1371/journal.pntd.0000861.t004
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tially breed in exposed human faeces [33], but is not found exiting
latrines [34]. Latrine access in The Gambia was 89.6%, and the
importance of latrine access has previously been demonstrated in
this setting [35]. However, access to a latrine does not necessarily
mean the latrine is used [36]. Previously in the same Tanzanian
district of Kongwa, Taylor et al. found an association between lack
of latrine access and TI. They also noted that only 59% of
households had access to a latrine, and 23.4% of these were non-
functional [37]. In a case-control study in the same Tanzanian
district, Montgomery et al. observed that latrine use was greater in
households that were trachoma-free than households containing a
case of active trachoma, and this association remained after
adjustment for potential confounders [22]. Thus, measurement of
latrine use, rather than latrine access, may be a more valuable
marker of the effect of latrines on trachoma prevalence.
In The Gambia, a primary water source more than 30 minutes
away was weakly associated with increased risk of TF. Interest-
ingly, time to fetch water was not a risk factor for TF in Tanzania.
Poor access to water was recently not reported as a risk factor for
active trachoma in a comparable study area of The Gambia [20],
whereas in Tanzania it is often an independent risk factor for
active trachoma [30,38]. Montgomery et al. found that there was
Table 5. Amplicor positive risk factor associations in children aged 0–5 years in The Gambia and Tanzania.
The Gambia Tanzania
Characteristic N
Amplicor
positive,
n (%) p-valuea N
Amplicor
positive,
n (%)
Unadjusted
OR (95% CI) p-valueb
Adjustedc OR
(95% CI) p-valued
Child level
Total 5036 39 (0.8) - 3122 684 (21.9) - - - -
Age (years) 0 792 4 (0.5) 0.791 550 61 (11.1) 1 ,0.001 1 -
1 805 9 (0.1) 468 76 (16.2) 1.96 (1.04–3.69) 1.70 (0.91–3.17) 0.095
2 801 5 (0.6) 569 122 (21.4) 4.89 (2.59–9.25) 4.03 (2.17–7.51) ,0.001
3 897 8 (0.9) 553 134 (24.2) 6.07 (3.25–11.3) 5.54 (3.00–10.2) ,0.001
4 824 6 (0.7) 504 156 (31.0) 12.0 (6.03–23.9) 11.2 (5.71–22.1) ,0.001
5 917 7 (0.8) 478 135 (28.2) 0.79 (4.89–19.6) 8.89 (4.56–17.7) ,0.001
Sex Female 2442 19 (0.8) 0.977 1539 355 (23.1) 1 0.260 1 0.293
Male 2594 20 (0.8) 1583 329 (20.8) 0.85 (0.65–1.12) 0.85 (0.62–1.16)
Ocular Discharge No 4578 32 (0.7) 0.044 2810 579 (20.6) 1 ,0.001 1 ,0.001
Yes 2594 7 (1.6) 301 101 (33.6) 2.39 (1.54–3.71) 2.56 (1.54–4.28)
Nasal Discharge No 3370 24 (0.7) 0.460 1579 311 (19.5) 1 1 0.036
Yes 1654 15 (0.9) 1513 369 (24.4) 1.55 (1.16–2.07) 0.002 1.42 (1.02–1.97)
Flies on the face No 4279 33 (0.8) 0.907 2937 622 (21.2) 1 - -
Yes 739 6 (0.8) 173 58 (33.5) 1.86 (1.04–3.33) 0.035 - -
Household level
Number of people/
household
All residents - - 0.134e - - 1.01 (0.95–1.08) 0.676 - -
Children 0–5 - - 0.140e - - 1.15 (0.96–1.38) 0.124 - -
Household head
educationf
Continuous - - - - - 0.92 (0.88–0.97) 0.001 - -
0 / 0-6 years 4736 36 (0.8) 0.646 1634 405 (24.8) 1 1 ,0.001
$1 / 7+ years 300 3 (1.0) 1486 278 (18.7) 0.55 (0.40–0.76) ,0.001 0.51 (0.35–0.74)
Time to water ,30 minutes 4323 32 (0.7) 0.495 720 122 (16.9) 1 0.017 1 0.090
$30 minutes 713 7 (1.0) 2401 562 (23.4) 1.74 (1.09–2.76) 1.58 (0.93–2.64)
Latrine access No 387 5 (1.3) 0.227 1066 263 (24.7) 1 0.048 - -
Yes 4649 34 (0.7) 2054 421 (20.5) 0.72 (0.51–1.00) - -
Health education
program
No 3343 28 (0.8) 0.359 1803 413 (22.9) 1 0.153 - -
Yes 1669 10 (0.6) 1159 227 (19.6) 0.78 (0.55–1.10) - -
OR =Odds Ratio; CI = Confidence Interval.
ap-value from chi-squared test;
bp-value from likelihood ratio test comparing random effects logistic regression models adjusting for between-household and between-cluster variation with and
without characteristic of interest;
cAdjusted for variables included in final multivariable regression model as shown;
dp-value from Wald test in multivariable regression analysis;
eWald p-value from logistic regression with robust standard errors;
freference category for The Gambia = 0 years and comparison category is $1 year; reference category for Tanzania = 0–6 years and comparison category is 7+ years.
Continuous education measure centred prior to regression modelling.
doi:10.1371/journal.pntd.0000861.t005
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an unadjusted association between households with worse access
to water and having a case of active trachoma [22]. Access to
water in this district has not changed in the past 20 years, as West
et al. (1989) documented that 79.8% of children came from
households more than 30 minutes away from the water source
[39], which is similar to the 76.9% found in our study. The lack of
an association in Tanzania despite no apparent change in access to
water indicates that interventions other than water supply
improvements may now be more important for trachoma control
in this area of Tanzania.
However, as with latrine access and use, access to water does
not necessarily correlate with behaviour change. In the study by
West et al. (1989), although there was a greater risk of having active
trachoma and an unclean face with increased distance to water,
these outcomes were not associated with the estimated amount of
water brought into the household [39]. In a Gambian study,
families with active trachoma were likely to use less water per
person per day to wash children than families with no cases of
active trachoma, after adjustment for family size, distance to water
and socio-economic indicators [40]. If it is assumed that discharge
is a causal factor in trachoma transmission, it is possible that a
combination of improved water access and community health
education may lead to cleaner faces and a consequent decline in
trachoma. However, as previously noted, interpretation of clean
face data is difficult, and a decline in unclean faces may not
correlate with a decline in trachoma.
In Tanzania only, an increased risk of TF was associated with
an increase in the number of children per household. In Tanzania,
West et al. similarly found an association between the number of
children per household and active trachoma [39], and in The
Gambia Bailey et al. observed that an increase in the number of
people per bedroom was associated with active trachoma [41].
The number of children in the household is used as a marker for
crowding, but the two are not necessarily correlated, as a few
people may live in a small house and many people may live in a
large house. A study in Mali showed that although increased risk of
active trachoma was associated with bedrooms in which there
were more than 4 people, it was also associated with households
containing less than 10 people compared with more than 10 [21].
Without an understanding of the household physical space, it is
not possible to determine whether a larger number of people is a
true marker of crowding.
Risk factors for evidence of infection differed between the
countries, largely due to the relative absence of Amplicor positives
in The Gambia and the associated lack of power to observe
associations. In Tanzania, where active trachoma and being
Amplicor positive were well associated, risk factors for TF and
Amplicor positivity were similar, although the environmental
factors of crowding and flies on the face were not related to being
Amplicor positive. In The Gambia, since ocular discharge was the
only factor associated with evidence of infection, it may be the key
infection transmission route at this low endemicity. We have
previously suggested that child-level factors should be the main
target for control interventions in this setting [20], and that
targeting children may eliminate the last reservoirs of infection.
As with any risk factor study reliant on a questionnaire, the
validity of the data is prone to responder bias. The questionnaires
were designed to be simple and appropriate for both countries for
logistic and comparability reasons. We therefore asked a limited
number of questions and did not support these with observational
data, such as evidence of water or latrine use, which may be better
measures of these trachoma risk factors [22,40]. The major
limitation of cross-sectional risk factor questionnaires is the
inability to determine causality. Thus, although active trachoma
and infection were both associated with ocular discharge in both
countries, this does not necessarily mean that ensuring the absence
of ocular discharge (such as through hygiene promotion) will aid
trachoma control. Furthermore, determination of an unclean face
may have been affected by the children’s faces being examined at
the time of screening, rather than in their household setting [24].
In the Gambian districts of Lower and Central Baddibu, the
prevalence of clinical signs appears to have decreased in the
absence of mass azithromycin treatment within the two years
preceding this study. Only one village was previously mass treated
in April 2006. The overall TF prevalence of 6.7% observed in this
study is lower than the prevalence of 10.7% found in children aged
1–9 years in a survey conducted in 2006 [5]. In 2006, the
prevalence of TF in 0–5 year-olds was 19.2% (19/99) in Lower
Baddibu and 25.0% (23/92) in Central Baddibu, whereas the
districts’ respective prevalences in the same age-group are now
9.2% and 10.1%. This is not surprising as the NECP has been
active since 1986, and over 85% of households have access to a
latrine and a water source within 30 minutes. The overall
prevalence of Amplicor positives in The Gambia in this study
was only 0.8%, similar to the 0.3% observed in 2006 [5]. These
results indicate that there is very little ocular C. trachomatis infection
remaining in The Gambia. This may explain the lower TF
prevalence in those aged under 1 year (1.6%) compared with the
older age groups who have a prevalence exceeding 6%. However,
the lower prevalence in the younger age group may be because
they have less exposure, or the follicular signs of trachoma only
appear after repeated or persistent infections and are therefore
rare in children aged less than 1 year. The lower prevalence may
also be due to the lack of ability to mount a follicular response to
organism in very young children. In older children, there may also
be some factor other than C. trachomatis infection causing follicles to
appear, such as other organisms like Moraxella and adenovirus
[7].
The difference between the two countries is further accentuated
by the association between presence of clinical signs and evidence
of infection. In The Gambia, the association was poor with only
0.9% of those with active trachoma being infected. In contrast,
38.9% of Tanzanian children with disease were Amplicor positive.
Interestingly, of the few cases with evidence of infection in The
Gambia, the majority did not fulfil the WHO criteria for active
trachoma. This could indicate that there was contamination of
samples or Amplicor false-positives. However, only one (0.4%) air
control was positive, the laboratory passed its standardisation with
the UCSF laboratory, and there were only 39 (0.8%) Amplicor
positives in total, indicating that the risk of contamination and
false-positives was low. The association in Tanzania was more
conventional, with most Amplicor positive individuals being
classified as also having active trachoma. Disease in Tanzania
was more severe than in The Gambia with a larger proportion of
children with clinical signs having TI, and these were more likely
to be Amplicor positive. As seen in other studies, the prevalence of
infection is associated with disease severity [10,42,43,44]. It is
likely that the distribution of mass treatment in Tanzania might
increase the disconnect between infection and disease, as infection
rapidly declines but clinical signs of trachoma persist [7,11,45,46].
Conclusion
In summary, this study showed that despite different preva-
lences of active trachoma and evidence of infection between the
Tanzanian and Gambian study sites, the risk factors for TF were
similar. The risk factors for being Amplicor positive in Tanzania
were similar to those for TF, whereas in The Gambia, only ocular
discharge was associated with evidence of C. trachomatis DNA,
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suggesting that at this low endemicity, this may be the most
important risk factor. The lack of an association between being
Amplicor positive and having TF in The Gambia highlights the
poor correlation between the presence of trachoma clinical signs
and evidence of C. trachomatis infection in this setting.
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Found at: doi:10.1371/journal.pntd.0000861.s001 (0.16 MB RTF)
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